ResMed Inc. reported its Q4 2025 earnings, revealing a robust financial performance with revenue reaching $1.35 billion, surpassing the forecast of $1.33 billion. Despite this positive financial ...
Influencer Jake Kind — known on TikTok as Goobi Gubbi — has finally opened the lockbox his late grandmother Mimmy left for his family in Switzerland after a two-week trip Mimmy, who was beloved on ...
ResMed was hit with a patent infringement lawsuit on Oct. 9 in California Southern District Court. The complaint, filed by Kobre & Kim on behalf of Spanish technology company Fractus, alleges willful ...
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential ...
ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.
Powered by rising margins, global growth, and confidence from management, this sleep tech stock is turning heads again. The New York Stock Exchange-listed ResMed Inc (NYSE: RMD) share price surged ...
Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share was 3% above ...
Resmed produces sleep apnoea machines and accompanying technology in Singapore and Australia, and the $49bn company confirmed this week its existing tariff exemption will continue in the US. Resmed ...
The CEO of ResMed, a $49b company which manufactures sleep devices to treat sleep apnea and other chronic respiratory conditions, on Thursday revealed the Trump Administration will not apply tariffs ...
April 23 (Reuters) - Resmed (RMD.N), opens new tab beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep ...
ResMed has appointed Salli Schwartz as the new Chief Investor Relations Officer, effective April 21, 2025. Schwartz brings over two decades of experience from roles in finance at health tech and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback